FDA Inspection
Lifecore Biomedical LLCLifecore Biomedical LLC – FDA Inspection, Feb 22, 2017
Record Details
This FDA Inspection record concerns Lifecore Biomedical LLC, with an inspection on February 22, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · ea191192-f285-4667-a709-095052c82eb4
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1008491
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
5- 21 CFR 211.110(a)Control procedures to monitor and validate performance
- 21 CFR 211.182Specific information required in individual logs
- 21 CFR 211.182Written records kept in individual logs
- 21 CFR 211.186(a)Signature and checking of records -- 2 persons
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Lifecore Biomedical LLC
12| Date | Classification | Office | Project area |
|---|---|---|---|
| March 12, 2025 | VAI | Minneapolis District Office | Drug Quality Assurance |
| February 26, 2019 | Not classified | Minneapolis District Office | |
| February 26, 2019 | OAI | Center for Drug Evaluation and Research | New Drug Evaluation |
| August 7, 2017 | Not classified | Minneapolis District Office | |
| August 7, 2017 | Not classified | Minneapolis District Office |
Other documents for Lifecore Biomedical LLC
- FDA Inspection 1252478 - 2025-03-12
- FDA Inspection 1086140 - 2019-02-26
- FDA Inspection 1082292 - 2019-02-26
- FDA Inspection 1022753 - 2017-08-07
- FDA Inspection 1022752 - 2017-08-07
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.